Business

Yasheng Group Resumes Plan to Pay Preferred Dividend to Common Shareholders; Raise Capital for our Subsidiary, Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to M

Yasheng Group Resumes Plan to Pay Preferred Dividend to Common Shareholders; Raise Capital for our Subsidiary, Jove Pharmaceutics In Order to Bring Next Generation Cancer Curing Cell Therapeutics to M.